These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36270251)

  • 21. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
    Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
    BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
    Khodaie F; Moghadasi AN; Hosseinnataj A; Baghbanian SM; Ashtari F; Razazian N; Poursadeghfard M; Majdi-Nasab N; Hatamian H; Hoseini S; Nahayati MA; Nabavi SM; Faraji F; Harirchian MH; Mir NHN; Moghadam NB; Sharifipour E; Bayati A; Kamali H; Mozhdehipanah H; Jalali N; Abotorabi-Zarchi M; Kamyari N; Nikbakht R; Azimi A; Navardi S; Heidari H; Sahraian MA; Eskandarieh S
    Clin Neurol Neurosurg; 2024 Apr; 239():108221. PubMed ID: 38447483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort.
    Katsavos S; Artemiadis A; Gontika M; Skarlis C; Markoglou N; Davaki P; Stamboulis E; Kilindireas K; Stefanis L; Anagnostouli M
    Postgrad Med; 2019 Sep; 131(7):490-495. PubMed ID: 31408393
    [No Abstract]   [Full Text] [Related]  

  • 24. Consanguinity and multiple sclerosis susceptibility: A case control study.
    Maghzi H; Shaygannejad V; Minagar A; Hassanzadeh A; Maghzi AH
    Mult Scler Relat Disord; 2016 Nov; 10():179-180. PubMed ID: 27919486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases.
    Steenhof M; Stenager E; Nielsen NM; Kyvik K; Möller S; Hertz JM
    Mult Scler Relat Disord; 2019 Jul; 32():97-102. PubMed ID: 31078918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial multiple sclerosis: does consanguinity have a role?
    Al Jumah M; Kojan S; Al Khathaami A; Al Abdulkaream I; Al Blawi M; Jawhary A
    Mult Scler; 2011 Apr; 17(4):487-9. PubMed ID: 21177327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis.
    Grudziecka Pyrek M; Selmaj K
    Front Neurol; 2022; 13():953188. PubMed ID: 36188381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.
    Ehtesham N; Rafie MZ; Mosallaei M
    BMC Neurol; 2021 Jun; 21(1):246. PubMed ID: 34182943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features of familial multiple sclerosis in Spain].
    Fernández-Pérez MJ; Barakat O; García-Moreno JM; Lucas M; Navarro G; Gata JM; Gamero MA; Duque P; Izquierdo G
    Rev Neurol; 1999 Oct 16-31; 29(8):693-6. PubMed ID: 10560101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
    Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis.
    Harirchian MH; Fatehi F; Sarraf P; Honarvar NM; Bitarafan S
    Mult Scler Relat Disord; 2018 Feb; 20():43-47. PubMed ID: 29291483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
    Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
    BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
    Eskandarieh S; Sahraiain MA; Molazadeh N; Moghadasi AN
    Mult Scler Relat Disord; 2019 Nov; 36():101377. PubMed ID: 31473489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran.
    Omrani MA; Bayati A; Sahraian MA; Eskandarieh S
    Curr J Neurol; 2023 Apr; 22(2):103-109. PubMed ID: 38011364
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence Trend of Gastrointestinal Cancer in Markazi, in the Center of Iran, Population-Based Cancer Registry Results: 2010-2014.
    Taheri M; Nazari J; Anoshirvani AA; Aghabozorgi R; Tabaeian SP; Bahrami M; Almasi-Hashiani A
    J Gastrointest Cancer; 2021 Sep; 52(3):915-921. PubMed ID: 32901447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
    Almasi-Hashiani A; Sahraian MA; Eskandarieh S
    BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
    Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
    Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.
    Ezabadi SG; Ayoubi S; Sahraian MA; Omrani MA; Eskandarieh S
    Neurol Sci; 2023 Dec; 44(12):4517-4518. PubMed ID: 37642789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.